FIELD: medicine, pharmacy.
SUBSTANCE: invention refers to medicine, namely to pediatrics, and concerns determination of type I diabetes compensation for adolescents. To do this, continuous monitoring of glucose and calculation of the average area under the glycemic curve in the hyper- and hypoglycemic range (AUC) during observation are performed. AUC values less than 1.18 mmol/l*h are regarded as compensation/subcompensation of T1D. At AUC level of 1.18 mmol/l*h and above T1D decompensation is diagnosed.
EFFECT: high accuracy evaluation of type 1 diabetes compensation for adolescents.
3 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PREPARATION FOR CONTROLLING GLYCEMIA LEVEL AND PREVENTION OF VASCULAR COMPLICATIONS IN PATIENTS WITH DISORDERS OF CARBOHYDRATE METABOLISM AND TYPE 2 DIABETES MELLITUS | 2009 |
|
RU2400245C1 |
| METHOD FOR ASSESSING GLYCEMIC VARIABILITY TO DETERMINE EFFECTIVENESS OF ANTIHYPERGLYCEMIC THERAPY IN PATIENTS WITH MODY2 DIABETES | 2020 |
|
RU2746830C1 |
| METHOD OF TREATING DIABETES MELLITUS IN OUTCOME OF TOTAL DUODENOPANCREATECTOMY | 2023 |
|
RU2823874C1 |
| METHOD OF DIAGNOSING EARLY NEUROLOGICAL DISORDERS IN PATIENTS WITH TYPE 1 DIABETES MELLITUS | 2021 |
|
RU2808480C2 |
| METHOD FOR PREDICTION OF CLINICAL COURSE OF TYPE 2 DIABETES MELLITUS WITH APPLICATION OF VARIOUS TYPES OF GLUCOSE-LOWERING THERAPY ON THE BASIS OF ESTIMATION OF GLYCEMIA VARIABILITY | 2019 |
|
RU2723626C1 |
| METHOD OF TREATMENT OF PATIENTS WITH DIABETES MELLITUS | 1996 |
|
RU2134109C1 |
| METHOD FOR DETERMINING AND CALCULATING THE NECESSARY REQUIRED INSULIN DOSE FOR TYPE SECONDARY DIABETES AND FORMED INSULIN DEPENDENCE | 2018 |
|
RU2684393C1 |
| METHOD OF PREDICTING RISK OF DEVELOPING DIABETIC NEPHROPATHY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND NORMAL BODY WEIGHT BASED ON GENOTYPING OF rs9920421 AND rs4932143 POLYMORPHISMS OF ANPEP GENE | 2023 |
|
RU2809443C1 |
| TREATING DIABETES MELLITUS WITH LONG-ACTING INSULIN FORMULATIONS | 2014 |
|
RU2705797C2 |
| METHOD OF EARLY DIAGNOSTICS OF COGNITIVE DISORDERS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS | 2015 |
|
RU2620550C1 |
